XIAP at the crossroads of cell death and inflammation
XIAP at the crossroads of cell death and inflammation |
https://doi.org/10.18632/oncotarget.25363
Domagoj Vucic
|
27319-27320 |
Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1
Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1 |
https://doi.org/10.18632/oncotarget.24535
Xing-Zhizi Wang,
Xiao-Ying Huang,
Jin-Guang Yao,
Chao Wang,
Qiang Xia,
and Xi-Dai Long
|
27321-27332 |
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease |
https://doi.org/10.18632/oncotarget.25542
Giuseppe Cammarata,
Simone Scalia,
Paolo Colomba,
Carmela Zizzo,
Antonio Pisani,
Eleonora Riccio,
Michaela Montalbano,
Riccardo Alessandro,
Antonello Giordano,
and Giovanni Duro
|
27333-27345 |
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors |
https://doi.org/10.18632/oncotarget.25213
Ewa Rupniewska,
Rajat Roy,
Francesco A. Mauri,
Xinxue Liu,
Maciej Kaliszczak,
Guido Bellezza,
Lucio Cagini,
Mattia Barbareschi,
Stefano Ferrero,
Anna M. Tommasi,
Eric Aboagye,
Michael J. Seckl,
and Olivier E. Pardo
|
27346-27362 |
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2)
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) |
https://doi.org/10.18632/oncotarget.25221
Carolina Garri,
Shannon Howell,
Katrin Tiemann,
Aleczandria Tiffany,
Farzad Jalali-Yazdi,
Mario M. Alba,
Jonathan E. Katz,
Terry T. Takahashi,
Ralf Landgraf,
Mitchell E. Gross,
Richard W. Roberts,
and Kian Kani
|
27363-27379 |
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations |
https://doi.org/10.18632/oncotarget.25270
Valentina Cocciolone,
Katia Cannita,
Alessandra Tessitore,
Valentina Mastroiaco,
Lucia Rinaldi,
Stefania Paradisi,
Azzurra Irelli,
Paola Lanfiuti Baldi,
Tina Sidoni,
Enrico Ricevuto,
Antonella Dal Mas,
Giuseppe Calvisi,
Gino Coletti,
Antonietta Ciccozzi,
Laura Pizzorno,
Valter Resta,
Alberto Bafile,
Edoardo Alesse,
and Corrado Ficorella
|
27380-27396 |
Cytogenetic damage analysis in mice chronically exposed to low-dose internal tritium beta-particle radiation
Cytogenetic damage analysis in mice chronically exposed to low-dose internal tritium beta-particle radiation |
https://doi.org/10.18632/oncotarget.25282
Sandrine Roch-Lefèvre,
Eric Grégoire,
Cécile Martin-Bodiot,
Matthew Flegal,
Amélie Fréneau,
Melinda Blimkie,
Laura Bannister,
Heather Wyatt,
Joan-Francesc Barquinero,
Laurence Roy,
Mohamed Benadjaoud,
Nick Priest,
Jean-René Jourdain,
and Dmitry Klokov
|
27397-27411 |
The landscape of somatic mutation in sporadic Chinese colorectal cancer
The landscape of somatic mutation in sporadic Chinese colorectal cancer |
https://doi.org/10.18632/oncotarget.25287
Zhe Liu,
Chao Yang,
Xiangchun Li,
Wen Luo,
Bhaskar Roy,
Teng Xiong,
Xiuqing Zhang,
Huanming Yang,
Jian Wang,
Zhenhao Ye,
Yang Chen,
Jinghe Song,
Shuai Ma,
Yong Zhou,
Min Yang,
Xiaodong Fang,
and Jie Du
|
27412-27422 |
Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma
Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma |
https://doi.org/10.18632/oncotarget.25384
Alexander Hendricks,
Greta-Lou Eggebrecht,
Alexander Bernsmeier,
Reinhild Geisen,
Katharina Dall,
Anna Trauzold,
Thomas Becker,
Holger Kalthoff,
Clemens Schafmayer,
Christian Röder,
and Sebastian Hinz
|
27423-27434 |
Synuclein gamma expression enhances radiation resistance of breast cancer cells
Synuclein gamma expression enhances radiation resistance of breast cancer cells |
https://doi.org/10.18632/oncotarget.25415
Lu Tian,
Yucui Zhao,
Marie-José Truong,
Chann Lagadec,
and Roland P. Bourette
|
27435-27447 |
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study |
https://doi.org/10.18632/oncotarget.25422
Maria Grazia Cerrito,
Marco De Giorgi,
Davide Pelizzoni,
Sara Maria Bonomo,
Nunzio Digiacomo,
Arianna Scagliotti,
Cristina Bugarin,
Giuseppe Gaipa,
Emanuela Grassilli,
Marialuisa Lavitrano,
Roberto Giovannoni,
Paolo Bidoli,
and Marina Elena Cazzaniga
|
27448-27459 |
PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy
PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy |
https://doi.org/10.18632/oncotarget.25446
Verena Rolfes,
Christian Idel,
Ralph Pries,
Kirstin Plötze-Martin,
Jens Habermann,
Timo Gemoll,
Sabine Bohnet,
Eicke Latz,
Julika Ribbat-Idel,
Bernardo S. Franklin,
and Barbara Wollenberg
|
27460-27470 |
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma |
https://doi.org/10.18632/oncotarget.25463
Yasuo Takashima,
Yasushi Sasaki,
Azusa Hayano,
Jumpei Homma,
Junya Fukai,
Yasuo Iwadate,
Koji Kajiwara,
Shin Ishizawa,
Hiroaki Hondoh,
Takashi Tokino,
and Ryuya Yamanaka
|
27471-27486 |
Anti-cancer binary system activated by bacteriophage HK022 integrase
Anti-cancer binary system activated by bacteriophage HK022 integrase |
https://doi.org/10.18632/oncotarget.25512
Amer Elias,
Natasha Gritsenko,
Rena Gorovits,
Itay Spector,
Gali Prag,
Ezra Yagil,
and Mikhail Kolot
|
27487-27501 |
Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT
Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT |
https://doi.org/10.18632/oncotarget.25514
Fanny Foubert,
Sébastien Gouard,
Catherine Saï-Maurel,
Michel Chérel,
Alain Faivre-Chauvet,
David M. Goldenberg,
Jacques Barbet,
Clément Bailly,
Caroline Bodet-Milin,
Thomas Carlier,
Kraeber-Bodéré Françoise,
Yann Touchefeu,
and Eric Frampas
|
27502-27513 |
Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers
Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers |
https://doi.org/10.18632/oncotarget.25518
Daisuke Fukagawa,
Tamotsu Sugai,
Mitsumasa Osakabe,
Yasuko Suga,
Takayuki Nagasawa,
Hiroaki Itamochi,
and Toru Sugiyama
|
27514-27524 |
Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population
Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population |
https://doi.org/10.18632/oncotarget.25537
Paula Silva Felicio,
Lucas Tadeu Bidinotto,
Matias Eliseo Melendez,
Rebeca Silveira Grasel,
Natalia Campacci,
Henrique C.R. Galvão,
Cristovam Scapulatempo-Neto,
Rozany Mucha Dufloth,
Adriane Feijó Evangelista,
and Edenir Inêz Palmero
|
27525-27534 |
High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids
High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids |
https://doi.org/10.18632/oncotarget.25541
Ida Rapa,
Arianna Votta,
Gaia Gatti,
Stefania Izzo,
Nicola Lo Buono,
Elisa Giorgio,
Simona Vatrano,
Francesca Napoli,
Aldo Scarpa,
Giorgio Scagliotti,
Mauro Papotti,
and Marco Volante
|
27535-27546 |
MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells |
https://doi.org/10.18632/oncotarget.25547
Ziv Versano,
Eitan Shany,
Shany Freedman,
Liron Tuval-Kochen,
Moshe Leitner,
Shoshana Paglin,
Amos Toren,
and Michal Yalon
|
27547-27563 |
Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary
Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary |
https://doi.org/10.18632/oncotarget.25548
Nobuhisa Yoshikawa,
Toshiya Teshigawara,
Yoshiki Ikeda,
Kimihiro Nishino,
Jun Sakata,
Fumi Utsumi,
Kaoru Niimi,
Ryuichiro Sekiya,
Shiro Suzuki,
Michiyasu Kawai,
Kiyosumi Shibata,
Fumitaka Kikkawa,
and Hiroaki Kajiyama
|
27564-27573 |
CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia
CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.24164
Xiaogang Sun,
Shuhong Huang,
Xin Wang,
Xiaohua Zhang,
and Xin Wang
|
27574-27584 |
Correction: 6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ
Correction: 6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ |
https://doi.org/10.18632/oncotarget.25638
Qinghe Han,
Qinghai Yuan,
and Guanghong Xie
|
27585-27585 |